Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis - Wikidata - wikimedia - TriplyDB

Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis

Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis

http://www.wikidata.org/entity/Q28362086

about

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS Androgen receptor (AR) in cardiovascular diseases Recent Advances in the Development of Experimental Animal Models Mimicking Human Aortic Aneurysms AT2 receptor activities and pathophysiological implications Angiotensin II blockade and aortic-root dilation in Marfan's syndrome Notch γ-secretase inhibitor dibenzazepine attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE knockout mice by multiple mechanisms Murine ultrasound imaging for circumferential strain analyses in the angiotensin II abdominal aortic aneurysm model The Murine Angiotensin II-Induced Abdominal Aortic Aneurysm Model: Rupture Risk and Inflammatory Progression Patterns.PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism.Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.The role of the renin-angiotensin system in aortic aneurysmal diseases.Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation.Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders.Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.In vivo quantification of murine aortic cyclic strain, motion, and curvature: implications for abdominal aortic aneurysm growth Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms.Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice.Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation.Experimental models of abdominal aortic aneurysms Curcumin Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm by Inhibition of Inflammatory Response and ERK Signaling Pathways.Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms Murine abdominal aortic aneurysm model by orthotopic allograft transplantation of elastase-treated abdominal aorta.Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.Angiotensin AT2 receptors: cardiovascular hope or hype?Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms Complex pathologies of angiotensin II-induced abdominal aortic aneurysms A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm Arrest of progression of pre-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by low level laser phototherapy.Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse.Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.Group V secretory phospholipase A2 enhances the progression of angiotensin II-induced abdominal aortic aneurysms but confers protection against angiotensin II-induced cardiac fibrosis in apoE-deficient mice.

P2860

Q24548457-4B352764-E9F6-49E7-B122-DC3395067417 Q24605300-03D3224C-A1E1-45A7-9858-F4B3C8347BB7 Q26771962-8A0FA16E-D609-4AE5-82AA-DBCECEC8EDAE Q26798395-F4966B5F-66F4-427D-9534-20818B0918D6 Q26829592-13015877-0DEF-4D19-BD4B-F36FE0F908A6 Q28285199-21094683-7034-418C-8CE3-B370553D7DB9 Q28537641-EDC11CC2-0EA5-4DA2-81CC-09DFA9A7154E Q30451599-1C4A9AD5-37EB-4018-9299-3A5CA21B1DE5 Q30501012-F16526B6-951E-4CCC-B6B8-94C1AB7680EE Q31115399-243C54B8-1D3A-4265-85B7-3292EA88AF61 Q33605449-692F9190-B052-402A-87DA-7AD22F3976D2 Q33738515-80808C23-952E-438F-9B97-766B44131B37 Q33757332-F3373D56-A837-45E2-AEDD-39F0F184A4AD Q33761769-578B0469-6119-4D3B-AE82-195EAEB3928D Q33947334-0B94EA5A-3581-4B18-B129-8B31C719610C Q33985855-E0ED6B43-A128-4299-B9C8-C4F8C013E8E5 Q34017755-3721947A-8BE2-414A-9251-2314BBAA6D20 Q34051477-8BC0FE77-0D67-41F5-AD6E-F4936726E5FF Q34286124-169D9BEB-2563-4AA9-99A7-FF869D347949 Q34506416-2B9DE1D3-D051-4141-84DE-D454B95765FC Q34507677-6F784CE5-F627-4BEA-9CA6-7F943FE10C44 Q34511040-1A77F205-4092-4B2E-A0B6-8780AF3EF59B Q34514569-5522682D-E195-4796-92F1-54DA0123B81D Q34518262-E5D41ADF-C0E0-448C-8AE0-C99018BFCB4E Q34560687-3C012CC9-DAD2-42C6-8D41-5CC304FA7DDE Q34576530-EF618B46-3522-402F-82B4-5058CB9A7CD1 Q34606642-34CECBB5-267D-4BA9-BBC8-2A2BEBE89473 Q34777411-D8632BD5-47C3-43B3-91D9-E392DF5A3082 Q34990858-287E834F-A676-47D3-9DCC-9B4DE4389635 Q35045801-621DB579-2619-462B-99DE-2B9CE51B42EC Q35048624-0C53D7C1-0D25-474E-B085-9A58D7036852 Q35148843-2F85BDE9-4730-4230-92EE-50A7AD7C007D Q35195538-7BE8B168-38F9-4B0C-BB24-DDCBA7AF128B Q35437077-A1B31451-FB9A-4B1C-A087-A16CD39F6F35 Q35837289-F5615BC2-C57E-4842-B7BA-48B7528AE585 Q35888165-A5477625-15BA-4A5F-8AF6-8AA140CE58AE Q35950321-E5140248-D846-4CF4-BFCB-A123394E7D31 Q36025434-868AFB4F-F112-4C0B-8325-FEB620654A9D Q36076407-8669C41D-A9B8-4856-863E-3FEA5324A21B Q36204176-6DF0FBD8-FB8D-4F69-B0C9-2A683E532A55

P2860

Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis

http://www.wikidata.org/entity/Q28362086

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

name

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@ast

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@en

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@nl

type

label

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@ast

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@en

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@nl

prefLabel

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@ast

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@en

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@nl

P1433

Q28362086-1BCDD9EC-DA4A-4825-AC77-01A435C36AE4

P1476

Q28362086-04AEDF51-A78C-4D08-8D5C-29815C3DD479

P2093

Q28362086-01922DE9-50D4-4AB4-9827-8B1F8068B96F

Q28362086-EB3F22EB-61B6-4ACF-AB00-C8F11DDB3589

Q28362086-EDC5D2AD-E144-402D-9F57-8EA7E8C161FE

P2860

Q28362086-3767525A-2D6A-401E-B64C-3042BCB813D3

Q28362086-37BE0BF0-0A63-450C-A24A-A7A722F6AE02

Q28362086-4B8A577C-C816-49FA-82E0-B72332C383F8

Q28362086-4D79D4E8-F90C-4A99-86D9-076A58B0BBE3

Q28362086-55E06FDB-D7E6-4AC1-9639-5630B41A4DBE

Q28362086-5753BE8C-9F0D-4FD9-ACD5-627FD106ACA9

Q28362086-7B613C87-E063-4630-9488-5263722DA17D

Q28362086-7CFDCB76-F5D0-4A63-95BB-70C59CC92FF2

Q28362086-83B5DB7A-5606-47BC-904A-1277AED27732

Q28362086-87077919-6A0A-4378-BCD8-0A101C4EFB5B

P304

Q28362086-34EBD8B3-A28C-4503-BFCD-EAD2D97FC4BE

P31

Q28362086-D1002D77-7765-4F95-BB32-6FD8FFDC8678

P3181

Q28362086-5C10BAB2-B624-4B17-B3B6-3A99AD754356

P356

Q28362086-7BE5260B-E1EF-47EE-ADFD-B376ACF6C16C

P407

Q28362086-DFFF8107-0536-491B-99D8-0C6BB7A24FDB

P433

Q28362086-276B08C0-2D91-4B74-A835-119DCF7D1012

P478

Q28362086-59272BB8-D32E-49AA-8E01-ABBD90F6BEF6

P577

Q28362086-DFB01006-CBEC-4460-8963-E5D24030EC27

P5875

Q28362086-92E81BA4-2F02-4AD2-9511-6F39F44EE1A7

P698

Q28362086-61FB52F8-8152-4A5A-9EE8-D2E1B16F57DF

P921

Q28362086-92970C68-3ABC-4089-A893-9C28D36F71DA

Q28362086-D6E6BF65-BE11-4F1F-A4B2-5D4EC1C4380D

P932

Q28362086-2C65E242-8C57-42FF-AD8D-290BFA4BB2D6

P3181

P356

P1433

British Journal of Pharmacology

P1476

Antagonism of AT2 receptors au ...... aneurysms and atherosclerosis

@en

P2093

A Daugherty

http://www.w3.org/2001/XMLSchema#string

L A Cassis

http://www.w3.org/2001/XMLSchema#string

M W Manning

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects

Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor.

Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function.

Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice.

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

The angiotensin II type 2 receptor: an enigma with multiple variations.

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis.

P304

865-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2870163

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJP.0704331

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11744874

http://www.w3.org/2001/XMLSchema#string

P698

11606327

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

1573019

http://www.w3.org/2001/XMLSchema#string